Pharma Focus America

LATEST NEWSRead more...

20

Jul 2024

Antheia Receives New Funding to Expand Domestic Manufacturing of Essential Pharmaceutical Ingredients

Antheia a company focused on revolutionizing essential medicine supply chains has announced the acquisition of million in new funding This includes a million nondilutive grant from the Biopharmaceutical

19

Jul 2024

ACROBiosystems Introduces New GMP Brand, Resilient Supply, at ISSCR to Enhance Cell and Gene Therapy Development

At the recent International Society for Stem Cell Research Annual Meeting in Hamburg ACROBiosystems introduced its new GMPcentered brand Resilient Supply aimed at accelerating the advancement of cell

19

Jul 2024

Parker Institute Invests Additional $125 Million in Ambitious Cancer Cure Initiative

The Parker Institute for Cancer Immunotherapy has secured a groundbreaking million investment the largest since its inception in This substantial funding boost is set to expand PICIs research

18

Jul 2024

SOTIO and Biocytogen Announce Collaboration to Expand ADC Development with Multi-Target Antibody Agreement

SOTIO Biotech a clinicalstage biopharmaceutical company under PPF Group and Biocytogen a global biotechnology firm listed on the Hong Kong Stock Exchange have entered into a research collaboration

18

Jul 2024

Biotheryx Commences Phase 1 Clinical Trial of BTX-9341, a Dual Bifunctional CDK4/6 Degrader, for HR+/HER2- Breast Cancer, Including Monotherapy and Combination with Fulvestrant

Biotheryx Inc a biopharmaceutical company focused on discovering and developing a new class of protein degraders has started a Phase clinical trial for BTX This investigational drug targets cyclindependent kinase

17

Jul 2024

SPI Pharma and Inimmune Corp. Partner to Create Innovative Vaccine Adjuvant Systems

SPI Pharma Inc and Inimmune Corp have entered into a strategic collaboration to develop and commercialize advanced adjuvant systems for vaccine development This partnership

press releasesRead more...

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules to Ease Administration for Patients Experiencing Dysphagia or Difficulty Swallowing

Neurocrine Biosciences Inc today announced the launch of a new sprinkle formulation of INGREZZA capsules the prescribed vesicular monoamine

Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility

Scorpius Holdings Inc an integrated contract development and manufacturing organization today announced the successful execution of its first current Good Manufacturing Practice microbial batches

Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy

Haystack Oncology a Quest Diagnostics company and Lisata Therapeutics Inc a clinicalstage pharmaceutical company developing innovative therapies

Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mild Alzheimer’s Disease

Longeveron Inc a clinical stage regenerative medicine biotechnology company developing cellular therapies for lifethreatening and chronic agingrelated

29 - 31

Jul 2024

29 - 31

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

15 - 16

Aug 2024

16 - 17

Aug 2024

iPharma Expo 2024

Boston, USA

21 - 22

Aug 2024
Testing The WorldCelebrating 70 Years of Nalgene
Thermo Fisher Scientific - mRNA Services
Future Labs Live USA 2024
World Vaccine Congress Europe 2024
World Orphan Drug Congress 2024
Advanced Therapies USA 2024
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 1

    The Role of mRNA Technology Beyond COVID-19 Vaccines: A New Era in Medicine

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 2

    Data Analytics and Forecasting in Pharmaceutical Distribution

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 3

    Addressing the Opioid Crisis: The Role of Pharmaceutical Companies

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 4

    The Future of Pharma: Integrating Imaging Informatics for Better Outcomes

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 5

    Innovative Technologies Driving Vaccine Research and Production: A Revolution in Healthcare

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

KNOWLEDGE BANK

EDITORIAL SECTION

  • Information Technology

    How AI is Transforming the Pharma Industry

    The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues